IMVT Jan 2025 40.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:02PM EDT. Market open.
| Previous Close | 4.2000 |
| Open | 4.3400 |
| Bid | 3.6000 |
| Ask | 5.6000 |
| Strike | 40.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 4.1000 - 4.4000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 2.22k |
ZacksZacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand have been highlighted in this Industry Outlook article.
Zacks5 Biotech Stocks Worth Adding to Your Portfolio in 2024
New drug approvals and pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position BMRN, BPMC, IMVT, KYMR and LGND well amid volatility.
Insider MonkeyShould You Hold Immunovant (IMVT)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
© 2024 Yahoo. All rights reserved.